Início › Câncer de Ovário › Missouri › St. Louis
Ensaios clínicos de Câncer de Ovário em St. Louis, MO
38 estudos para Câncer de Ovário estão buscando participantes em locais em St. Louis e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
The Vanguard Study: Testing a New Way to Screen for Cancer
RecrutandoVoluntários saudáveis bem-vindos
- Washington University School of Medicine, St Louis
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
RecrutandoFase 3
- Washington University School of Medicine in St. Louis, St Louis
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
RecrutandoFase 2/3
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- e mais 2
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecrutandoFase 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- e mais 6
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RecrutandoFase 1
- Washington University Medicine, St Louis
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RecrutandoFase 1
- Washington University School of Medicine in St. Louis, St Louis
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RecrutandoFase 2
- Washington University, School of Medicine, St Louis
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
Recrutando
- WU St Louis, St Louis
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
RecrutandoFase 1/2
- Washington University, St Louis
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RecrutandoFase 2
- Mercy David C. Pratt Cancer Center /ID# 275655, St Louis
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecrutandoEstudo observacional
- Washington University, St Louis
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RecrutandoFase 1
- Washington University School of Medicine in St. Louis, St Louis
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RecrutandoFase 1/2
- Washington Univ. School of Medicine, St Louis
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RecrutandoFase 3
- Mercy Hospital St. Louis - David C. Pratt Cancer Center, St Louis
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RecrutandoFase 2
- Washington University, St Louis
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RecrutandoFase 1/2
- Research Site, St Louis
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
RecrutandoFase 3
- Washington University School of Medicine ( Site 0052), St Louis
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
RecrutandoFase 3
- Washington University School of Medicine, St Louis
- Mercy Hospital St. Louis, St Louis
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecrutandoFase 1/2
- Washington University School of Medicine, St Louis
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RecrutandoFase 1
- Washington University, Siteman Cancer Center, St Louis
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RecrutandoFase 1
- Normunity Investigational Site, St Louis
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Recrutando
- Washington University School of Medicine, St Louis
- Missouri Baptist Medical Center, St Louis
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecrutandoFase 3
- Mercy Infusion Center - Chippewa, St Louis
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- e mais 5
IDOV-Immune for Advanced Solid Tumors
RecrutandoFase 1
- Washington University School of Medicine, St Louis
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- Washington University, St Louis
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
RecrutandoFase 2/3
- Washington University School of Medicine Obstetrics and Gynecology, St Louis
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RecrutandoFase 1
- Investigative Site #110, St Louis
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RecrutandoFase 2
- 521, St Louis
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RecrutandoFase 1/2
- Washington University, St Louis
Lead-212 PSV359 Therapy for Patients With Solid Tumors
RecrutandoFase 1/2
- Saint Louis University, St Louis
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RecrutandoFase 1/2
- Washington University, St Louis
Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
RecrutandoFase 1
- Washington University School of Medicine in St. Louis, St Louis
JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
RecrutandoFase 1/2
- Research site, St Louis
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
RecrutandoFase 3
- Washington University School of Medicine, St Louis
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
RecrutandoFase 1
- Site 0111, St Louis
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
Recrutando
- Washington University Medical Center, St Louis
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
RecrutandoFase 2
- Washington University, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, St Louis
Ensaios de Câncer de Ovário em outras cidades
- Houston, TX89 estudos
- New York City, NY69 estudos
- Boston, MA61 estudos
- Los Angeles, CA50 estudos
- Nashville, TN49 estudos
- Arlington, VA46 estudos
- Philadelphia, PA44 estudos
- Columbus, OH39 estudos
- Chicago, IL36 estudos
- San Antonio, TX31 estudos
- Cleveland, OH30 estudos
- Pittsburgh, PA30 estudos
Outros estudos em St. Louis
- Câncer de Pulmão de Não Pequenas Células73 estudos
- Câncer de Mama64 estudos
- Câncer Metastático54 estudos
- Câncer Colorretal50 estudos
- Câncer (todos os tipos)46 estudos
- Câncer de Próstata46 estudos
- Câncer de Pulmão39 estudos
- Câncer de Pâncreas33 estudos
- Câncer Endometrial29 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço28 estudos
- Insuficiência Cardíaca26 estudos
- Obesidade25 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.